GlassScriptPhysician profile
Rica N Howarth
NPI 1952530503
$10,410.49
in general payments reported to CMS, 2019-2025
17 companies · $719 in 2025
The $719 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $979 · 2022: $1,411 · 2023: $7,300 · 2025: $719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,894 · Honoraria: $1,400 · Food and Beverage: $1,373 · Education: $203 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,893.75 |
| Honoraria | $1,400.00 |
| Food and Beverage | $1,373.13 |
| Education | $202.77 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,547.97 | 2021-2023 | |
| Sk Life Science, INC. | $2,348.03 | 2021-2023 | Xcopri |
| Emd Serono, INC. | $861.48 | 2021-2025 | Mavenclad |
| Biogen, INC. | $505.70 | 2021-2025 | Tysabri |
| Livanova USA, INC. | $161.03 | 2021-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Novartis Pharmaceuticals Corporation | $129.53 | 2021-2022 | |
| Lundbeck LLC | $124.04 | 2023 | Vyepti |
| Geron Corporation | $122.66 | 2025 | Rytelo |
| Biohaven Pharmaceutical Holding Company LTD. | $122.62 | 2022 | |
| Merck Sharp & Dohme LLC | $106.99 | 2025 | Keytruda |
| Lilly USA, LLC | $105.87 | 2025 | |
| Pfizer INC. | $105.54 | 2023-2025 | |
| Caris Mpi, INC. | $66.52 | 2025 | Mi Cancer Seek |
| Neurocrine Biosciences, INC. | $40.21 | 2022-2023 | Ingrezza, Ongentys |
| Biohaven Pharmaceuticals, INC. | $25.08 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $23.54 | 2025 | Polivy |
| Allergan, INC. | $13.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rica Howarth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.